PK and Safety Study of Natroba Topical Suspension 0.9% in Subjects 1 Month to 3 Years 11 Months of Age with Scabies
- First Posted Date
- 2022-04-05
- Last Posted Date
- 2025-02-14
- Lead Sponsor
- Cipher Pharmaceuticals Inc.
- Target Recruit Count
- 50
- Registration Number
- NCT05310734
- Locations
- πΊπΈ
L&C Professional Medical Research Institute, Miami, Florida, United States
πΊπΈVelocity Clinical Research, Lafayette, Louisiana, United States
πΊπΈElixir Research Group, Houston, Texas, United States
Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne
- First Posted Date
- 2009-09-11
- Last Posted Date
- 2014-07-04
- Lead Sponsor
- Cipher Pharmaceuticals Inc.
- Target Recruit Count
- 925
- Registration Number
- NCT00975143
- Locations
- π¨π¦
UltraNova Skincare, Barrie, Ontario, Canada
π¨π¦Institute of Cosmetic and Laser Surgery, Oakville, Ontario, Canada
π¨π¦Dermatrials Research, Hamilton, Ontario, Canada
Β© Copyright 2025. All Rights Reserved by MedPath